LV10040B - Tablets, method of their preparation, granulates and method of their preparation - Google Patents

Tablets, method of their preparation, granulates and method of their preparation Download PDF

Info

Publication number
LV10040B
LV10040B LVP-92-168A LV920168A LV10040B LV 10040 B LV10040 B LV 10040B LV 920168 A LV920168 A LV 920168A LV 10040 B LV10040 B LV 10040B
Authority
LV
Latvia
Prior art keywords
mesna
weight
parts
sowie
und
Prior art date
Application number
LVP-92-168A
Other languages
English (en)
Latvian (lv)
Other versions
LV10040A (lv
Inventor
Dieter Sauerbier
Juergen Prof Dr Engel
Eckhard Dr Milsmann
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of LV10040A publication Critical patent/LV10040A/xx
Publication of LV10040B publication Critical patent/LV10040B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Glanulating (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LVP-92-168A 1990-07-16 1992-10-27 Tablets, method of their preparation, granulates and method of their preparation LV10040B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4022525 1990-07-16
SG142394A SG142394G (en) 1990-07-16 1994-10-03 Tablet and granulate containing mesna as active agent

Publications (2)

Publication Number Publication Date
LV10040A LV10040A (lv) 1994-05-10
LV10040B true LV10040B (en) 1995-06-20

Family

ID=25895027

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-168A LV10040B (en) 1990-07-16 1992-10-27 Tablets, method of their preparation, granulates and method of their preparation

Country Status (31)

Country Link
US (1) US5262169A (hu)
EP (1) EP0468245B1 (hu)
JP (1) JP3068894B2 (hu)
KR (1) KR100189666B1 (hu)
CN (1) CN1072484C (hu)
AT (1) ATE104548T1 (hu)
AU (1) AU638586B2 (hu)
BG (2) BG60851B1 (hu)
CA (1) CA2047027C (hu)
DE (2) DE59101431D1 (hu)
DK (1) DK0468245T3 (hu)
EG (1) EG20019A (hu)
ES (1) ES2063412T3 (hu)
FI (1) FI97949C (hu)
HK (1) HK129894A (hu)
HR (1) HRP920889B1 (hu)
HU (1) HU206630B (hu)
IE (1) IE65373B1 (hu)
IL (1) IL98836A (hu)
LT (1) LT3527B (hu)
LV (1) LV10040B (hu)
MC (1) MC2273A1 (hu)
MX (1) MX174407B (hu)
NO (1) NO178362C (hu)
NZ (1) NZ238941A (hu)
PT (1) PT98325B (hu)
RO (1) RO113713B1 (hu)
RU (1) RU2070040C1 (hu)
SG (1) SG142394G (hu)
SI (1) SI9111226A (hu)
ZA (1) ZA915515B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE9321574U1 (de) * 1992-03-11 2000-06-29 Asta Medica Ag Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen
US5773031A (en) * 1996-02-27 1998-06-30 L. Perrigo Company Acetaminophen sustained-release formulation
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
EP0955040A1 (de) 1998-04-27 1999-11-10 ASTA Medica Aktiengesellschaft Arzneiform zur oralen Applikation von Mesna
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US6075053A (en) * 1999-02-09 2000-06-13 Bionumerik Pharmaceuticals, Inc. Method of reducing or reversing neuropathy
WO2009022430A1 (en) * 2007-08-10 2009-02-19 Ki Pharmaceuticals, Inc. Skin whitening agent
CA2902911C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734418A (en) * 1984-12-14 1988-03-29 Mitsui Petrochemical Industries, Ltd. Quinazoline compounds and antihypertensives
IT1185551B (it) * 1985-04-15 1987-11-12 Schering Spa Composizioni farmaceutiche a base di acido mercaptoetansolfonico ad attivita' terapeutica,derivati salini organici dell'acido mercaptoetansolfonico utili per tali composizioni e relativo procedimento di preparazione
DE58900183D1 (de) * 1988-03-19 1991-08-29 Asta Pharma Ag Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.

Also Published As

Publication number Publication date
RO113713B1 (ro) 1998-10-30
IE912463A1 (en) 1992-01-29
KR100189666B1 (ko) 1999-06-01
HU912374D0 (en) 1991-12-30
MC2273A1 (fr) 1993-06-23
DE4122167A1 (de) 1992-01-23
DE59101431D1 (de) 1994-05-26
NO912771L (no) 1992-01-17
FI913409A (fi) 1992-01-17
RU2070040C1 (ru) 1996-12-10
AU638586B2 (en) 1993-07-01
LTIP920A (en) 1995-03-27
BG60851B1 (bg) 1996-05-31
BG60901B1 (bg) 1996-06-28
JPH04230319A (ja) 1992-08-19
EP0468245A1 (de) 1992-01-29
CN1058337A (zh) 1992-02-05
US5262169A (en) 1993-11-16
SI9111226A (en) 1995-04-30
IL98836A0 (en) 1992-07-15
JP3068894B2 (ja) 2000-07-24
IL98836A (en) 1994-11-28
PT98325B (pt) 1999-01-29
CN1072484C (zh) 2001-10-10
HU206630B (en) 1992-12-28
KR920002154A (ko) 1992-02-28
BG96200A (bg) 1993-12-24
FI97949C (fi) 1997-03-25
ZA915515B (en) 1992-04-29
NO178362B (no) 1995-12-04
BG94824A (bg) 1993-12-24
HRP920889A2 (en) 1996-04-30
HRP920889B1 (en) 1998-02-28
EG20019A (en) 1997-01-30
FI97949B (fi) 1996-12-13
ES2063412T3 (es) 1995-01-01
ATE104548T1 (de) 1994-05-15
FI913409A0 (fi) 1991-07-15
DK0468245T3 (da) 1994-05-16
LT3527B (en) 1995-11-27
SG142394G (en) 1995-01-13
NZ238941A (en) 1993-03-26
HK129894A (en) 1994-12-02
CA2047027A1 (en) 1992-01-17
LV10040A (lv) 1994-05-10
CA2047027C (en) 1996-09-17
PT98325A (pt) 1992-05-29
MX174407B (es) 1994-05-13
EP0468245B1 (de) 1994-04-20
AU8044591A (en) 1992-01-16
NO912771D0 (no) 1991-07-15
HUT59317A (en) 1992-05-28
NO178362C (no) 1996-03-13
IE65373B1 (en) 1995-10-18

Similar Documents

Publication Publication Date Title
EP0032562B1 (de) Neue Dipyridamol-Retardformen und Verfahren zu ihrer Herstellung
EP0620731B1 (de) Pharmazeutische zubereitung in form einer brause- und/oder zerfallstablette oder eines instantgranulats, sowie verfahren zu ihrer herstellung
DE60023465T2 (de) Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser
EP0069259B1 (de) Bromhexin-Retardform und Verfahren zu ihrer Herstellung
EP1435915B1 (de) Orale darreichungsformen für propiverin oder seinen pharmazeutisch annehmbaren salzen mit verlängerter wirkstofffreisetzung
EP0560092B1 (de) Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen
AT398166B (de) Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung von nitrofurantoin (-salzen, -hydraten, -komplexen)
EP0122574B1 (de) Teilbare Tablette mit verzögerter Wirkstofffreigabe und Verfahren zu deren Herstellung
DE2949119A1 (de) Pharmazeutisches vehikel und dieses enthaltende allmaehlich freisetzende pharmazeutische zusammensetzung
DE3627423A1 (de) Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
DE4332394A1 (de) Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
DE69014691T2 (de) Verfahren zur Herstellung von Bromocriptin enthaltenden Arzneimittelzubereitungen mit hoher Stabilität und in Beziehung zueinander stehende Produkte.
WO2011032912A1 (de) Pharmazeutische zusammensetzung mit den wirkstoffen metformin und sitagliptin oder vildagliptin
WO1992005774A1 (de) Lösungsmittelfreie, oral zu verabreichende pharmazeutische zubereitung mit verzögerter wirkstofffreisetzung und verfahren zu deren herstellung
DE1467781A1 (de) Verfahren zur Herstellung von Dragees mit verlaengerter Wirkstofffreigabe
LV10040B (en) Tablets, method of their preparation, granulates and method of their preparation
DE2128461A1 (de) Pharmazeutisches Präparat
EP1762231B1 (de) Magnesium-Mikrotabletten mit verzögerter Freisetzung
DE60104442T2 (de) Neue galenische dispergierbare und lösliche paracetamol-zubereitung, methode zu deren herstellung und deren anwendungen
EP1216043B1 (de) Alpha-liponsäure(-derivate)enthaltende retardform
WO1998056359A2 (de) Zusammensetzungen, die die wirkstofffreisetzung verzögern
AT503858B1 (de) Verfahren zur herstellung einer festen oralen pharmazeutischen zusammensetzung, enthaltend ein jodsalz
AT347039B (de) Verfahren zur herstellung von tabletten und dragees mit einem gehalt an zwei verschiedenen heilmittelwirkstoffen mit verzoegerter wirk- stoffabgabe
DE69002477T2 (de) Salsalat-Tablette.
DE2621906C2 (hu)